Global Cord Blood's GAAP net income for fiscal year 2022 was CN¥509.483 million, down 1.3% from CN¥516.205 million in the previous year. Revenue increased 7.2% to CN¥1.243 billion from CN¥1.16 billion a year earlier.

Global Cord Blood's GAAP net income for the first nine months of fiscal 2022 was CN¥ 402.685 million, up 4.3% from CN¥ 385.904 million in the previous year. Revenue increased 10.3% to CN¥ 946.046 million from CN¥ 857.318 million a year earlier.

Global Cord Blood's GAAP net income for 6M 2022 fiscal year was CN¥267.128 million, down 0.2% from CN¥267.747 million in the prior year. Revenue increased 11% to CN¥628.844 million versus CN¥566.52 million a year earlier.

Global Cord Blood's GAAP net income for 3M 2022 fiscal year was CN¥138.986 million, up 3.4% from CN¥134.425 million in the prior year. Revenue increased 12.2% to CN¥315.174 million from CN¥280.913 million a year earlier.